Please note that the ANZCTR website will be unavailable from 1:00pm until 2:30pm (AEST) on Thursday 5th June for website maintenance.
Please be sure to log out of the system in order to avoid any loss of data. Thank you and apologies for any inconvenience caused.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12625000526471p
Ethics application status
Submitted, not yet approved
Date submitted
13/04/2025
Date registered
26/05/2025
Date last updated
26/05/2025
Date data sharing statement initially provided
26/05/2025
Type of registration
Prospectively registered

Titles & IDs
Public title
Exercise for diabetes-related foot wounds
Scientific title
Exercise for diabetes-related foot wounds: A randomised feasibility trial
Secondary ID [1] 314191 0
MRFCDDM000062
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Diabetes-related foot wounds 337055 0
Condition category
Condition code
Metabolic and Endocrine 333499 333499 0 0
Diabetes
Physical Medicine / Rehabilitation 333589 333589 0 0
Other physical medicine / rehabilitation

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
An individualised 12-week exercise program supervised by an Accredited Exercise Physiologist delivered three times a week at a face-to-face appointment.
Each exercise session will last for a approximately 30 minutes and will involve a 5-minute warm-up followed by 10 minutes of aerobic exercise (e.g. limb cycling), 10 minutes of resistance exercises (e.g., chest press and leg curls) and then a 5-minute a cool-down. Exercise intensity will be monitored and gradually increased using a perceived exertion scale (Borg’s scale).
All exercises will be tailored to the participant's need and will include lower limb exercises where possible. Attendance, participation and safety will be documented at the end of every session.
Intervention code [1] 330793 0
Treatment: Other
Comparator / control treatment
Standard podiatry care and medical care in line with International Working Group on the Diabetic Foot (IWGDF) Guidelines
Control group
Active

Outcomes
Primary outcome [1] 341076 0
Safety
Timepoint [1] 341076 0
Weekly during the 12-week intervention
Primary outcome [2] 341321 0
Feasibility (participant recruitment)
Timepoint [2] 341321 0
Baseline
Primary outcome [3] 341322 0
Feasibility (acceptability)
Timepoint [3] 341322 0
At the end of the 12-week intervention
Secondary outcome [1] 446100 0
Wound healing
Timepoint [1] 446100 0
Baseline, 12-week follow-up and 24-week follow-up post-commencement of intervention
Secondary outcome [2] 446106 0
Physical function
Timepoint [2] 446106 0
Baseline, 12-week follow-up and 24-week follow-up post-commencement of intervention
Secondary outcome [3] 446107 0
Diabetes management
Timepoint [3] 446107 0
Baseline, 12-week follow-up and 24-week follow-up post-commencement of intervention
Secondary outcome [4] 446108 0
Wellbeing
Timepoint [4] 446108 0
Baseline, 12-week follow-up and 24-week follow-up post-commencement of intervention
Secondary outcome [5] 446614 0
Quality of life
Timepoint [5] 446614 0
Baseline, 12-week follow-up and 24-week follow-up post-commencement of intervention
Secondary outcome [6] 446615 0
Anxiety
Timepoint [6] 446615 0
Baseline, 12-week follow-up and 24-week follow-up post-commencement of intervention.
Secondary outcome [7] 446616 0
Frailty
Timepoint [7] 446616 0
Baseline, 12-week follow-up and 24-week follow-up post-commencement of intervention.
Secondary outcome [8] 447992 0
Depression
Timepoint [8] 447992 0
Baseline, 12-week follow-up and 24-week follow-up post-commencement of intervention.
Secondary outcome [9] 448051 0
PRIMARY OUTCOME: Feasibility (participant engagement)
Timepoint [9] 448051 0
Baseline, 12-week follow-up and 24-week follow-up post-commencement of intervention
Secondary outcome [10] 448052 0
PRIMARY OUTCOME: Feasibility (participant retention)
Timepoint [10] 448052 0
12-week follow-up and 24-week follow-up post-commencement of intervention

Eligibility
Key inclusion criteria
People with a diabetes-related foot wound

Wound, Ischemia, and Foot Infection (WIfI) wound score equal or greater than 1

Able to understand English to provide informed consent and complete questionnaires.
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Foot ulcer in the absence of diabetes

Active infection with systemic symptoms

TCPO2 or Toe Pressures <30mmHg and requiring surgery.

Surgical wounds (<4weeks)

Patients requiring a wheelchair on a regular basis.


Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocation concealment
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
1:1 randomisation stratified according to wound type
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Single group
Other design features
Phase
Not Applicable
Type of endpoint/s
Safety
Statistical methods / analysis
Analysis of feasibility measures will be analysed descriptively

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
SA

Funding & Sponsors
Funding source category [1] 318443 0
Government body
Name [1] 318443 0
Government Department of Health and Aged Care: The Medical Research Future Fund (MRFF) Targeted Translation Research Accelerator – Cardiovascular Disease and Diabetes Mechanisms grant opportunity
Country [1] 318443 0
Australia
Primary sponsor type
University
Name
University of South Australia
Address
Country
Australia
Secondary sponsor category [1] 320839 0
Government body
Name [1] 320839 0
Central Adelaide Local Health Network Inc
Address [1] 320839 0
Country [1] 320839 0
Australia

Ethics approval
Ethics application status
Submitted, not yet approved
Ethics committee name [1] 317061 0
Central Adelaide Local Health Network HREC
Ethics committee address [1] 317061 0
Ethics committee country [1] 317061 0
Australia
Date submitted for ethics approval [1] 317061 0
17/03/2025
Approval date [1] 317061 0
Ethics approval number [1] 317061 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 139870 0
Dr Lisa Matricciani
Address 139870 0
University of South Australia, City East, North Terrace, Adelaide, SA, 5000
Country 139870 0
Australia
Phone 139870 0
+61 8 83025993
Fax 139870 0
Email 139870 0
Contact person for public queries
Name 139871 0
Lisa Matricciani
Address 139871 0
University of South Australia, City East, North Terrace, Adelaide, SA, 5000
Country 139871 0
Australia
Phone 139871 0
+61 8 83025993
Fax 139871 0
Email 139871 0
Contact person for scientific queries
Name 139872 0
Lisa Matricciani
Address 139872 0
University of South Australia, City East, North Terrace, Adelaide, SA, 5000
Country 139872 0
Australia
Phone 139872 0
+61 8 83025993
Fax 139872 0
Email 139872 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.